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It is associated with reduced quality of life, impaired functional status, poor physical and mental health, and increased mortality. 2 There is a broad international consensus 3,4 that multi morbidity is best addressed in primary care set tings by a patientcentred approach, including reg ular appointments for comprehensive problem review and management options tailored to individual patient preferences. This care should be provided by a multi disciplinary team with a named lead clinician, and should be based on effective clinical information systems.
But there remains the essential question of whether patientcentred interventions actually improve out comes for patients living with multimorbidity and the health systems that care for them. The results of a recent Cochrane review 5 of 18 randomised controlled trials were equivocal, reporting little or no difference in clinical outcomes or in health service use, while suggesting that health outcomes could be improved if interventions are targeted at specific risk factors or functional difficulties.
Chris Salisbury and colleagues 6 help answer this question using findings from their clusterrandomised trial of the 3D approach (three dimensional approach based on dimensions of health, depression, and drugs), presented in The Lancet. Their UKbased, multisite trial is the largest study to my knowledge of patientcentred care for multimorbidity. Despite implementing all of the recommended elements of patientcentred care, the authors found no evidence of a significant effect on quality of life (the difference in mean EQ5D5L scores was 0·00, 95% CI -0·02 to 0·02; p=0·93), or on various measures of illness or treatment burden. 6 The authors did, however, find that participants randomly assigned to the intervention group reported significantly improved patientcentred care, including discussing problems most important to them (42% in the intervention group vs 26% in the usual care group; odds ratio 1·85, 95% CI 1·44 to 2·38; p<0·0001) and satisfaction with care received (56% vs 39%; 1·57, 1·19 to 2·08; p=0·0014). 6 The 3D approach was based on the best available evidence from international clinical guidelines. Built around two 6monthly appointments with a nurse and a physician, and medication review by a pharmacist, it was crafted and designed to be pragmatic and achievable. The findings should therefore be assumed to be robust and generalisable across the National Health Service. The findings are also likely to be of relevance in other healthcare systems based on well established primary care teams with a commitment to reducing the burden of chronic disease.
Although the findings of Salisbury and colleagues might encourage people committed to single disease management approaches, it would be premature to consign patientcentred multimorbidity care to the dustbin of medical history. The core components of the intervention could have been insufficient to treat deeprooted health problems, especially since only 49% of the intervention participants attended both appointments. Despite specific pharmacist review, there was no difference in rates of prescription of poten tially inappropriate medications. Trials of longerterm inter ventions, involving greater intensity of contact between patients and healthcare professionals, are therefore indicated.
It is implausible to assume that the organisation and delivery of even the highest quality primary care is sufficient in itself to address the complexity of multimorbidity, the underlying causes of which are often rooted in socioeconomic deprivation. 7 It would there fore be advisable to develop multmodal approaches, linking patientcentred primary care with public health policy level interventions addressing behavioural, environmental, and occupational determinants of long term illness and inequity. 8 As the authors note, the study results call into question the assumed causal link between patientcentred care and improved quality of life and health outcomes. Although such a link has been a standard assumption in primary care for many years, and is commonly seen as the underlying reason for holistic approaches to health care, 9, 10 it is important to acknowledge that this assumption needs to be challenged and tested.
This raises a further question, whether patient centred care for patients with multimorbidity is a means to an end, or an end in itself. In the study by Salisbury and colleagues, quality of life and disease management out comes were no worse than those for standard care, so there is no evidence of the trial intervention doing harm. I await the results of the health economics analyses from this study, which will be published separately. Assuming comparability, it will be reasonable to conclude that, given competing models of service delivery providing equivalent health care, modes of delivery that are rated more highly by patients 11 are intrinsically preferable.
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